Are you Dr. Piepkorn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2330 130th Ave NE
Ste 201
Bellevue, WA 98005Phone+1 425-455-9945Fax+1 425-455-9947
Summary
- Dr. Michael Piepkorn, MD is a board certified dermatologist in Bellevue, Washington. He is currently licensed to practice medicine in Washington, Montana, and Utah. He is affiliated with UW Medicine/University of Washington Medical Center and UW Medicine/Harborview Medical Center.
Education & Training
- University of WashingtonResidency, Dermatology, 1978 - 1980
- University of WashingtonResidency, Pathology-Anatomic and Clinical, 1974 - 1978
- HealthPartners Institute/Regions HospitalInternship, Transitional Year, 1973 - 1974
- University of Minnesota Medical SchoolClass of 1973
Certifications & Licensure
- MT State Medical License 2010 - 2026
- WA State Medical License 1975 - 2026
- UT State Medical License 1980 - 1992
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 54 citationsDysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.A. R. Shors, S. Kim, E. White, Zsolt B. Argenyi, Raymond L. Barnhill
The British Journal of Dermatology. 2006-11-01 - 16 citationsDiameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: a case-control study.Michael Y. Xiong, Michael S. Rabkin, Michael Piepkorn, Raymond L. Barnhill, Zsolt B. Argenyi
Journal of the American Academy of Dermatology. 2014-12-01 - 23 citationsConcordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging ManualJoann G. Elmore, David E. Elder, Raymond L. Barnhill, Stevan R. Knezevich, Gary Longton
JAMA Network Open. 2018-05-18
Press Mentions
- Want a Second Opinion? UCLA Study Demonstrates Doctors Can Be Influenced by the First Diagnoses – Sometimes Towards MisdiagnosisAugust 10th, 2022
- New Guidelines May Slightly Increase Reliability, Accuracy of Melanoma DiagnosesMay 18th, 2018
- Analysis of EHR Pathology Reports Aids Understanding of Skin BiopsiesNovember 22nd, 2017
- Join now to see all
Grant Support
- Autocrine Regulation Of KeratinocytesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2001
- Glycosaminoglycans Of Skin TumorsNational Cancer Institute1987–1990
- Glycosaminoglycans Of Skin TumorsNational Cancer Institute1986
Professional Memberships
- Fellow